ArticleJournal of the American Association for Laboratory Animal Science : JAALAS2025
Optimization of Ketamine/Xylazine Anesthesia in Geriatric Mice.
Article in Journal of the American Association for Laboratory Animal Science : JAALAS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aged mice are becoming increasingly important models for human senescence. Many studies require anesthesia. Standard rodent ketamine/xylazine injectable regimens have been associated with increased incidences of death, unreliable surgical planes, and prolonged recoveries in geriatric mice. We hypothesized that the addition of atipamezole reversal and higher doses of ketamine or xylazine would result in a more reliable surgical plane of anesthesia and quicker recovery in geriatric mice without increasing mortality. Mice (n = 6 per group) were subjected to one of 3 anesthetic regimens: 100 mg/kg ketamine and 10 mg/kg xylazine without reversal (Standard); 150 mg/kg ketamine and 10 mg/kg xylazine with 1 mg/kg atipamezole reversal (High Ketamine); or 100 mg/kg ketamine and 15 mg/kg xylazine with 1 mg/kg atipamezole reversal (High Xylazine). While anesthetized, righting reflex, pedal withdrawal reflex, heart rate, respiratory rate, arterial oxygen saturation (SpO2), and temperature were recorded. While both experimental groups provided a more consistent surgical plane of anesthesia, the High Ketamine group had both the longest anesthetic period and the highest mortality (33.3%). The High Xylazine group had moderate mortality (16.6%) and a comparable anesthetic period to the Standard regimen, along with a superior SpO2 to both groups. Atipamezole reversal led to a faster return of righting reflex and an increase in SpO2 but did not affect the total length of recovery compared with the Standard group that did not include a reversal agent. Overall, the High Xylazine group provided a more reliable surgical plane to the Standard group in geriatric mice but increased mortality (16.6%), and the addition of atipamezole as a reversal agent did not significantly change the length of recovery. The information gained from this study can help guide decisions regarding the use of ketamine and xylazine in geriatric mice for surgical procedures or lengthy procedures for which redosing might be necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.